Andrew Vickers (@vickersbiostats) 's Twitter Profile
Andrew Vickers

@vickersbiostats

Biostatistician at Memorial Sloan Kettering Cancer Center. Special interest in prostate cancer, risk prediction, patient-reported outcomes, decision-making.

ID: 1225800762447532034

linkhttps://www.mskcc.org/profile/andrew-vickers calendar_today07-02-2020 15:17:42

2,2K Tweet

5,5K Followers

72 Following

Andrew Vickers (@vickersbiostats) 's Twitter Profile Photo

When an RCT and an observational study have virtually identical results, you can be a little more definitive: ePLND offers zero biochemical recurrence benefits but does reduce metastasis